IL6 and cancer: In triple-negative breast cancer (TNBC), cancer cell-derived IL-6 have been reported to stimulate the polarization of macrophages toward M2 phenotype, and thus promotes epithelial-mesenchymal transition (EMT) and invasion of TNBC cells (Weng et al., 2019).